Semi-annual evaluation report on the company's "Improving Quality and Efficiency, Returning to Profit" action plan for 2024 of Remegen Pharmaceutical (Yantai) Co., Ltd.
Remegen Pharmaceutical (Yantai) Co., Ltd. Announcement of Resolutions of the 12th Meeting of the Second Session of the Supervisory Board.
Special Report on the Use and Deposit of Funds Raised by Remegen Biopharmaceutical (Yantai) Co., Ltd. in the First Half of 2024.
Announcement on the Change of Some Senior Management Personnel at Remegen Biopharmaceutical (Yantai) Co., Ltd.
Remegen's explanation on the use of the raised funds in technology innovation field (Revised draft).
Remegen's Second Supervisory Committee's Eleventh Meeting Resolution Announcement.
Remegen announces the resolution of the 14th meeting of the second Board of Directors.
RemeGen Co., Ltd.: Announcement listed in Hong Kong
Remegen Pharma (Yantai) Co., Ltd.'s stocks experienced abnormal fluctuations in trading, according to an announcement.
Reply to the Inquiry Letter regarding Unusual Fluctuation in Trading of Stocks of Remegen Biopharmaceutical (Yantai) Co., Ltd.
RemeGen Co., Ltd.: Investor Relations Activity Record Form for July 9th, 2024
RemeGen Co., Ltd.: Investor Relations Activity Record June 19, 2024
Announcement listed in Hong Kong
Rongchang Biotech's announcement on the completion of some fund-raising special account sales
Announcement of Resolutions of the 13th Meeting of the 2nd Board of Directors of Rongchang Biotech
Rongchang Biopharmaceutical (Yantai) Co., Ltd. 2023 Environmental, Social and Governance Report
Announcement of Resolutions of the 10th Meeting of the 2nd Board of Supervisors of Rongchang Biotech
Rongchang Biotech's announcement on adjusting the 2024-2025 daily related transaction forecast
Huatai United Securities Co., Ltd.'s verification opinion on Rongchang Biopharmaceutical (Yantai) Co., Ltd.'s adjustment of the 2024-2025 daily related transaction forecast
Rongchang Biotech's announcement on the completion of some fund-raising projects and permanently supplementing working capital with savings raised
No Data